Jan Nyman

Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy

Pia Baumann, Jan Nyman, Berit Wennberg et al. · Journal of Clinical Oncology · 2009 · 838 citations · Full text

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

Charles Butts, Mark A. Socinski, Paul Mitchell et al. · The Lancet Oncology · 2013 · 520 citations · Full text

Oncology, Medicine, Metronomic Therapy +8

SPACE – A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC

Jan Nyman, Andreas Hallqvist, Jo-Åsmund Lund et al. · Radiotherapy and Oncology · 2016 · 339 citations · Full text

Inoperable Stage, Radiation Medicine, Radiation Therapy +8

Prognostic factors for acute and late skin reactions in radiotheraphy patients

Ingela Turesson, Jan Nyman, Erik Holmberg et al. · International Journal of Radiation Oncology*Biology*Physics · 1996 · 311 citations

Prognostic Factors, Skin Testing, Skin Allergy +8

Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patients

Jan Nyman, Karl-Axel Johansson, Ulla Hultén · Lung Cancer · 2005 · 246 citations

Radiation Medicine, Radiation Therapy, Medicine +7